10:36 AM EDT, 06/25/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday it will collaborate with OpenAI to use generative artificial intelligence technology to develop antimicrobials to treat drug-resistant pathogens.

The collaboration backs Lilly's pledge to fight drug-resistant pathogens via its Social Impact Venture Capital Portfolio, the company said.

Financial details about the collaboration weren't provided.

Price: 898.78, Change: +8.67, Percent Change: +0.97